Jing Si Herbal Tea as Adjuvant Treatment in Patients With Chronic Pelvic Pain Syndrome

Starting soon · Not applicable · Has a placebo group

Conditions studied: Chronic Pelvic Pain Syndrome (CPPS)

In brief

The purpose of this clinical trial is to evaluate the efficacy of Jing Si Herbal Tea as an adjuvant treatment for patients diagnosed with Chronic Pelvic Pain Syndrome (CPPS). The study aims to determine whether adding Jing Si Herbal Tea to standard care can improve clinical symptoms and quality of life in these patients.

Key facts

Study ID

NCT07357142

Run by

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

People needed

400

Starts

2026-03-01

Expected to finish

2030-12-31

Last updated by the study team

2026-02-04

Who can join

Age: 18 and older, up to 100. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male patients.
• Diagnosed with Chronic Pelvic Pain Syndrome (CPPS) at the investigational site.
• Currently receiving continuous follow-up and medical treatment.

You may not qualify if…

• Female patients (Excluded because the standard treatment, alpha-blockers, is not approved or reimbursed by the National Health Insurance for this indication in women in Taiwan).
• Duration of symptoms less than 3 months.
• History of recurrent urinary tract infections.
• Diagnosed with malignancy.
• Hospitalization for other diseases within the past 3 months.
• Unwilling to participate in the study.

Where it is running

• Taipei Tzu Chi Hospital — New Taipei City, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.